These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23472504)

  • 1. How to treat Parkinson's disease in 2013.
    Worth PF
    Clin Med (Lond); 2013 Feb; 13(1):93-6. PubMed ID: 23472504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Parkinson's disease : what's on the horizon?
    Wu SS; Frucht SJ
    CNS Drugs; 2005; 19(9):723-43. PubMed ID: 16142989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Parkinson's disease.
    Martin WR; Wieler M
    Can J Neurol Sci; 2003 Mar; 30 Suppl 1():S27-33. PubMed ID: 12691474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for Parkinson's disease.
    Koller WC
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S155-9. PubMed ID: 9749588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Parkinson's Disease.
    Tarakad A; Jankovic J
    Semin Neurol; 2017 Apr; 37(2):118-126. PubMed ID: 28511252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease.
    Church FC
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    van der Kolk NM; de Vries NM; Kessels RPC; Joosten H; Zwinderman AH; Post B; Bloem BR
    Lancet Neurol; 2019 Nov; 18(11):998-1008. PubMed ID: 31521532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: diagnosis and treatment.
    Rao SS; Hofmann LA; Shakil A
    Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in the pharmacological treatment of Parkinson's disease.
    Tuite P; Riss J
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1335-52. PubMed ID: 12882620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease.
    Björklund T; Carlsson T; Cederfjäll EA; Carta M; Kirik D
    Brain; 2010 Feb; 133(Pt 2):496-511. PubMed ID: 20129936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of pharmacological treatment for Parkinson's disease.
    Almeida QJ; Hyson HC
    Recent Pat CNS Drug Discov; 2008 Jan; 3(1):50-4. PubMed ID: 18221241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons.
    Kim GJ; Mo H; Liu H; Wu Z; Chen S; Zheng J; Zhao X; Nucum D; Shortland J; Peng L; Elepano M; Tang B; Olson S; Paras N; Li H; Renslo AR; Arkin MR; Huang B; Lu B; Sirota M; Guo S
    Elife; 2021 Sep; 10():. PubMed ID: 34550070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.
    Radad K; Gille G; Rausch WD
    Pharmacol Rep; 2005; 57(6):701-12. PubMed ID: 16382188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy in Parkinson's disease: rationale and current status.
    Feng LR; Maguire-Zeiss KA
    CNS Drugs; 2010 Mar; 24(3):177-92. PubMed ID: 20155994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
    Scherbaum R; Hartelt E; Kinkel M; Gold R; Muhlack S; Tönges L
    J Neurol; 2020 Apr; 267(4):954-965. PubMed ID: 31797086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.
    Dodel RC; Berger K; Oertel WH
    Pharmacoeconomics; 2001; 19(10):1013-38. PubMed ID: 11735671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits and mechanisms of exercise training for Parkinson's disease.
    Feng YS; Yang SD; Tan ZX; Wang MM; Xing Y; Dong F; Zhang F
    Life Sci; 2020 Mar; 245():117345. PubMed ID: 31981631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.